Proteomic analysis to identify markers for response to neoadjuvant treatment in esophageal and gastroesophageal cancer

BACKGROUND: Esophageal cancer represents a global challenge. Despite significant evolution of treatment protocols in the past decade, recurrence rates are still high and survival rates are poor. Current treatment paradigm for localized gastroesophageal junction (GEJ) carcinoma remains to be further...

Descripción completa

Detalles Bibliográficos
Autores principales: Zlotnik, Oran, Goshen‐Lago, Tal, Haddad, Riad, Brenner, Baruch, Kundel, Yulia, Ben‐Aharon, Irit, Kashtan, Hanoch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955071/
https://www.ncbi.nlm.nih.gov/pubmed/34350714
http://dx.doi.org/10.1002/cnr2.1489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955071/
https://www.ncbi.nlm.nih.gov/pubmed/34350714
http://dx.doi.org/10.1002/cnr2.1489

Ejemplares similares